Extensive aortic root endocarditis with extension into the intervalvular fibrous body: an updated report of a mitral valve sparing approach
European Journal of Cardio-Thoracic Surgery · 2023
DOI: 10.1093/ejcts/ezad114 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Anton Tomšič und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden, Netherlands. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Heart Valve Prosthesis, Endocarditis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVES Aortic root abscess can spread to include adjacent cardiac structures, including the central or intervalvular fibrous body and mitral valve. After radical debridement, complex surgical correction is needed. We describe the results of our mitral valve sparing approach. METHODS Between January 2004 and December 2020, 60 patients underwent operation for infective endocarditis of the aortic root with extension towards the mitral valve at 2 centres in the Netherlands. Early and late clinical and echocardiographic outcomes were studied. RESULTS Prosthetic valve endocarditis was present in 42 (70%) patients and emergent or salvage surgery was performed in 8 (13%) patients. After radical debridement of all infected tissue, mitral valve repair was feasible in 48 (80%) patients. Early mortality occurred in 11 (18%) patients while mechanical circulatory support was needed in 8 (13%) patients. At 10 years after surgery, the estimated reintervention-free survival rate was 51.9% (95% confidence interval 37.0–66.8%). Eight patients underwent reintervention; this was more common in patients who underwent aortic valve rather than root replacement and in patients in whom mitral valve repair was performed without ring annuloplasty. For 48 patients who underwent mitral valve repair, the estimated freedom from recurrent mitral regurgitation rate was 64.4% (95% confidence interval 40.1–88.7%) at 10 years after surgery. CONCLUSIONS Surgical intervention for extensive infective endocarditis of the aortic root is related to reasonable perioperative morbidity and mortality. Optimal surgical technique is crucial to lower the risk of late reintervention. Mitral valve repair is feasible in the majority of patients with satisfactory durability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden, Netherlands.
- Department of Cardiothoracic Surgery, Amsterdam University Medical Centre, Amsterdam, Netherlands.
- Department of Cardiology, Leiden University Medical Centre, Leiden, Netherlands.
ORCID-Profile: Meindert Palmen, Jerry Braun, Robert J M Klautz
Zitieren
APA
Tomšič, A., Palmen, M., de Jong, M. L., Hjortnaes, J., Driessen, A. G. H., Braun, J., Marsan, N. A., & Klautz, R. J. M. (2023). Extensive aortic root endocarditis with extension into the intervalvular fibrous body: an updated report of a mitral valve sparing approach. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad114
Vancouver
Tomšič A, Palmen M, de Jong ML, Hjortnaes J, Driessen AGH, Braun J, et al. Extensive aortic root endocarditis with extension into the intervalvular fibrous body: an updated report of a mitral valve sparing approach. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad114
BibTeX
@article{Tomi2023,
author = {Tomšič, Anton and Palmen, Meindert and de Jong, Mylene Loncq and Hjortnaes, Jesper and Driessen, Antoine G H and Braun, Jerry and Marsan, Nina Ajmone and Klautz, Robert J M},
title = {Extensive aortic root endocarditis with extension into the intervalvular fibrous body: an updated report of a mitral valve sparing approach},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
doi = {10.1093/ejcts/ezad114}
}
EUVIMED